Being the nation’s only producer of the anthrax vaccine has made Lansing’s
Emergent BioSolutions a big deal for years. Soon, a $108 million investment will make the company’s campus on Martin Luther King Jr. Boulevard look like a big deal too.
The first phase of improvements will come in the form of a $9.6 million, 32,000-square foot, three-story administration building including offices, conference rooms and an employee workout facility that will become the new face of company.
“This building will be a very aesthetically pleasing gateway to our campus” says Jessi Wortley, communications specialist for Emergent BioSolutions. “We are very excited.”
Aesthetics aren’t the primary motivation for the improvements, however. A five-year plan will bring the total investment up to $108 million and will include such developments as new warehouse space and a new science building, enough to allow the company’s production of the anthrax vaccine to double.
“We’ve run out room,” says Wortley. “The company has been growing so rapidly, we’re up over 400 employees at our facilities here in Lansing.”
Approximately 50 of those employees have been added over the past year, and Wortley expects the number of new jobs to continue to grow over the next year.
Construction on the new administration building is pending the approval of a brownfield tax credit approval. According to Wortley, Emergent BioSolutions hopes to begin work on the facility in June.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.